Microbiology

  1. A single-dose live-attenuated YF17D-vectored SARS-CoV2 vaccine candidate

    1. Lorena Sanchez Felipe
    2. Thomas Vercruysse
    3. Sapna Sharma
    4. Ji Ma
    5. Viktor Lemmens
    6. Dominique van Looveren
    7. Mahadesh Prasad Arkalagud Javarappa
    8. Robbert Boudewijns
    9. Bert Malengier-Devlies
    10. Suzanne F. Kaptein
    11. Laurens Liesenborghs
    12. Carolien De Keyzer
    13. Lindsey Bervoets
    14. Madina Rasulova
    15. Laura Seldeslachts
    16. Sander Jansen
    17. Michael Bright Yakass
    18. Osbourne Quaye
    19. Li-Hsin Li
    20. Xin Zhang
    21. Sebastiaan ter Horst
    22. Niraj Mishra
    23. Lotte Coelmont
    24. Christopher Cawthorne
    25. Koen Van Laere
    26. Ghislain Opdenakker
    27. Greetje Van de Velde
    28. Birgit Weynand
    29. Dirk E. Teuwen
    30. Patrick Matthys
    31. Johan Neyts
    32. Hendrik Jan Thibaut
    33. Kai Dallmeier

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Continuous flexibility analysis of SARS-CoV-2 Spike prefusion structures

    1. Roberto Melero
    2. Carlos Oscar S. Sorzano
    3. Brent Foster
    4. José-Luis Vilas
    5. Marta Martínez
    6. Roberto Marabini
    7. Erney Ramírez-Aportela
    8. Ruben Sanchez-Garcia
    9. David Herreros
    10. Laura del Caño
    11. Patricia Losana
    12. Yunior C. Fonseca-Reyna
    13. Pablo Conesa
    14. Daniel Wrapp
    15. Pablo Chacon
    16. Jason S. McLellan
    17. Hemant D. Tagare
    18. Jose-Maria Carazo

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs

    1. Lei Sun
    2. Pan Li
    3. Xiaohui Ju
    4. Jian Rao
    5. Wenze Huang
    6. Lili Ren
    7. Shaojun Zhang
    8. Tuanlin Xiong
    9. Kui Xu
    10. Xiaolin Zhou
    11. Mingli Gong
    12. Eric Miska
    13. Qiang Ding
    14. Jianwei Wang
    15. Qiangfeng Cliff Zhang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Extracellular vesicles containing ACE2 efficiently prevent infection by SARS‐CoV‐2 Spike protein‐containing virus

    1. Federico Cocozza
    2. Nathalie Névo
    3. Ester Piovesana
    4. Xavier Lahaye
    5. Julian Buchrieser
    6. Olivier Schwartz
    7. Nicolas Manel
    8. Mercedes Tkach
    9. Clotilde Théry
    10. Lorena Martin‐Jaular

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Inactivation analysis of SARS-CoV-2 by specimen transport media, nucleic acid extraction reagents, detergents and fixatives

    1. Stephen R. Welch
    2. Katherine A. Davies
    3. Hubert Buczkowski
    4. Nipunadi Hettiarachchi
    5. Nicole Green
    6. Ulrike Arnold
    7. Matthew Jones
    8. Matthew J. Hannah
    9. Reah Evans
    10. Christopher Burton
    11. Jane E. Burton
    12. Malcolm Guiver
    13. Patricia A. Cane
    14. Neil Woodford
    15. Christine B. Bruce
    16. Allen D. G. Roberts
    17. Marian J. Killip

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 in vitro infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19

    1. Douglas Ferreira Sales-Medina
    2. Ludmila Rodrigues Pinto Ferreira
    3. Lavínia M. D. Romera
    4. Karolina Ribeiro Gonçalves
    5. Rafael V. C. Guido
    6. Gilles Courtemanche
    7. Marcos S. Buckeridge
    8. Édison L. Durigon
    9. Carolina B. Moraes
    10. Lucio H. Freitas-Junior

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Decline of humoral responses against SARS-CoV-2 Spike in convalescent individuals

    1. Guillaume Beaudoin-Bussières
    2. Annemarie Laumaea
    3. Sai Priya Anand
    4. Jérémie Prévost
    5. Romain Gasser
    6. Guillaume Goyette
    7. Halima Medjahed
    8. Josée Perreault
    9. Tony Tremblay
    10. Antoine Lewin
    11. Laurie Gokool
    12. Chantal Morrisseau
    13. Philippe Bégin
    14. Cécile Tremblay
    15. Valérie Martel-Laferrière
    16. Daniel E. Kaufmann
    17. Jonathan Richard
    18. Renée Bazin
    19. Andrés Finzi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model

    1. Jean-Sélim Driouich
    2. Maxime Cochin
    3. Guillaume Lingas
    4. Grégory Moureau
    5. Franck Touret
    6. Paul Rémi Petit
    7. Géraldine Piorkowski
    8. Karine Barthélémy
    9. Bruno Coutard
    10. Jérémie Guedj
    11. Xavier de Lamballerie
    12. Caroline Solas
    13. Antoine Nougairède

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Comparison of three TaqMan Real-Time Reverse Transcription-PCR assays in detecting SARS-CoV-2

    1. Yan Xiao
    2. Zhen Li
    3. Xinming Wang
    4. Yingying Wang
    5. Ying Wang
    6. Geng Wang
    7. Lili Ren
    8. Jianguo Li

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection

    1. Raveen Rathnasinghe
    2. Shirin Strohmeier
    3. Fatima Amanat
    4. Virginia L. Gillespie
    5. Florian Krammer
    6. Adolfo García-Sastre
    7. Lynda Coughlan
    8. Michael Schotsaert
    9. Melissa Uccellini

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 51 of 252 Next